HYDRAZIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR
申请人:Miyaji Katsuaki
公开号:US20090253751A1
公开(公告)日:2009-10-08
Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided.
A compound represented by the formula (I) (wherein R
1
, R
2
, R
3
, L
1
, L
2
, X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.